Surveillance Activities. 1. Aerial surveillance activities during the withdrawal will be carried out as follows:
a. Both Parties request the United States to continue airborne surveillance flights in accordance with previous agreements until the completion of final Israeli withdrawal.
b. Flight profiles will cover the Limited Forces Zones to monitor the limitations on forces and armaments, and to determine that Israeli armed forces have withdrawn from the areas described in Article II of Annex I, Article II of this Appendix, and Maps 2 and 3, and that these forces thereafter remain behind their lines. Special inspection flights may be flown at the request of either Party or of the United Nations.
c. Only the main elements in the military organizations of each Party, as described in Annex I and in this Appendix, will be reported.
2. Both Parties request the United States operated Sinai Field Mission to continue its operations in accordance with previous agreements until completion of the Israeli withdrawal from the area east of the Giddi and Mitla Passes. Thereafter, the Mission be terminated.
Surveillance Activities. Continued development of epidemic thresholds for SARI surveillance based on the Moving Epidemic Method. • Supported strengthening of influenza surveillance in the region, including assistance to SEE countries through a CoAg with CDC. • Expanded the Flu Awareness Campaign, a multimedia event, with six member states participating in the 2014–2015 season. • Developed tools to support reviewing, monitoring and strengthening national surveillance systems, including an electronic surveillance assessment tool and a feasibility tool for select SARI sentinel sites. • Enhanced disease surveillance for severe influenza in the region, with 15 countries routinely conducting SARI surveillance by 2015. • Conducted inter-country meetings and missions to three countries to support calculation of estimates of clinical and economic influenza burden. • Continued the development of guidelines to increase influenza vaccine uptake in targeted populations (i.e. pregnant women and health care workers) based on the Tailoring Immunization Programmes for Influenza.
Surveillance Activities. Conducted a review of the influenza sentinel surveillance system in December 2014 in collaboration with CDC and the Council of State and Territorial Epidemiologists (CSTE).
Surveillance Activities. Reviewed the status of influenza virological surveillance in the African region from 2010 to 2013. Results were published in the November 2014 edition of the Integrated Disease Surveillance and Response quarterly bulletin. • Worked with the respective governments of Burundi and Mauritania to conduct an assessment of their influenza surveillance systems (July/ August 2014). The assessment revealed that both countries do not have functional virological and epidemiological influenza surveillance systems in place. • Attended the 4th African Network Influenza Surveillance and Epidemiology (ANISE) Meeting held in Cape Town, South Africa (5–6 Dec 2014) and chaired a session on “Setting the Stage
Surveillance Activities. Assembled a project focused on surveillance at three pig farms to explore the human-animal interface. • Completed the influenza-specific SARI project in October 2013 and implemented a general SARI surveillance system. • Managed ILI and SARI surveillance, including sampling and analysis. • Organized the 4th Annual Meeting for SARI site managers in Antananarivo (July 2014). • Tested 2,583 specimens for influenza diagnosis between October 1, 2013 and April 19, 2015. Among all specimens, 311 were SARI cases that were tested at the NIC using an in-house panel system for the detection of respiratory viruses. Submitted 32 positive isolates and 34 positive swabs to the WHO Collaborating Center (CC) • Completed the WHO External Quality Assessment Project (EQAP) Panel 13. • Investigated a bronchiolitis epidemic in Antananarivo in a children’s hospital in early March; results highlighted RSV and human metapneumovirus infections in 67% of specimens collected. • Improved the SARI surveillance system by training 61 clinicians from 17 hospitals from July 15–18, 2014. • Conducted training on Risk Communication in Mauritius with 20 participants from nine countries (December 2014). • Supported the Ministry of Health of Madagascar in updating the national contingency plan for 2014–2016. • Trained Ministry of Health staff on case definition and containment of suspected cases with regard to the Ebola outbreak in West Africa. • International Grant Management Training Course for CDC Grantees in Antananarivo, Madagascar, 24–28 February 2014. • Workshop on introduction to empirical population genetics, Institut Pasteur de Madagascar, Antananarivo, Madagascar, 19–23 May 2014. • Burden of Influenza Disease Workshop, Cape Town, South Africa, 4 December 2014. • International Workshop on Risk Communication Related to Public Health Emergency, Flic-en-Flac, Mauritius, 15–17 December 2014. • CDC/APHL International Workshop on Influenza rRT-PCR Diagnosis, Institut Pasteur de Madagascar, Antananarivo, Madagascar, 27–30 January 2015. • Procured laboratory supplies and reagents. • Assessed the national epidemiological surveillance system. • Enhanced the national influenza surveillance protocol. • Selected and activated sentinel sites.
Surveillance Activities. The Client agrees to cooperate and facilitate the surveillance activities as laid down in the certification requirements.
Surveillance Activities. 1. Conduct active surveillance and reporting activities for HIV/AIDS.
2. Be responsible to DSHS for the maintenance and operation of an active surveillance system for HIV/AIDS cases, as detailed herein. For the purpose of this Contract, “HIV infection” and “AIDS” are as defined by the Centers for Disease Control and Prevention (CDC) of the United States Public Health Service (MMWR. Recommendations and Reports. December 5, 2008 57(RR10);1-8), located at xxxx://xxx.xxx.xxx/mmwr/preview/mmwrhtml/rr5710a1.htm.
3. Maintain a current list of key reporting sources (as defined in the Texas HIV Surveillance Procedure Manual) in Grantee’s designated Service Area and include this information in Grantee’s tracking tool. The tracking tool must be available to monitoring team during site evaluations. Grantee must conduct visits with each of these sources at least once during the term of this Contract to establish and maintain communication about reporting requirements (including cluster and data to care HIV surveillance) and any changes in any relevant surveillance procedures and requirements.
4. Ensure the completeness of case reporting provided to DSHS by conducting the following activities at least monthly, or as indicated: compare the expected number of cases to current year-to-date number of cases reported (based on the previous 5-year average over the same area); Grantee is encouraged to implement additional methods of evaluating, reporting, and ensuring completeness from key reporting sources.
5. Provide information, feedback, and clarification, as directed by DSHS Central Office staff, within ten (10) working days of inquiry.
6. Conduct quarterly active case findings, in collaboration with regional staff, by contacting (by phone or in person) all HIV reporting facilities in the coverage area and collecting information necessary to complete an HIV/AIDS case report form on any newly diagnosed HIV/AIDS cases during the quarter.
Surveillance Activities. Enhanced the epidemiologic capacity and infrastructure for disease surveillance, including the development of quantitative criteria to determine the epidemic start and geographic spread of influenza for separate cities, federal districts, and the country. • Developed a written sustainability plan and included a draft in the Order of Ministry of Healthcare and Rospotrebnadzor. • Obtained results from the first national disease burden estimates.
Surveillance Activities. Coordinated the epidemiology and laboratory sectors of both the MOH and veterinary authorities to improve national risk assessment for avian influenza and other zoonotic diseases. • Conducted multiple field investigations for communicable diseases, assessing both the epidemiologic and environmental situation in various governorates. • Conducted field visits to monitor influenza A (H5N1) virus national surveillance sites and provide on-the-job training. • Established unified database for acute respiratory illness (ARI) and influenza surveillance. • Provided reports online for sentinel surveillance sites (ILI/SARI). • Improved diagnostic capacity of the subnational laboratories. • Expanded geographical representativeness of influenza surveillance, early detection, and
Surveillance Activities. Developed a new logistics plan for transporting samples between sentinel sites and the National Influenza Center (NIC) on dry ice. • Performed supervisory visits to influenza sentinel sites in Odessa and Khmelnitsliy. • Organized training for all participants of sentinel surveillance. • Carried out quality SARI surveillance and established that there was a high correlation between the number of SARI cases and the percent of influenza-positive samples. • Prepared an additional draft order aimed at improving surveillance. This order is under consideration in the Ministry of Health.
